In general, further studies with different cell lines, different disease models, and larger cohorts are essential to validate the findings of the current study and validate the translational potential of the YAP/HIF-1α/miR-182/EGR2 signaling axis in asthma. This evidence concerns the gene EGR2 and asthma.